Cardica To Present At 2014 Wedbush PacGrow Life Sciences Management Access Conference

  Cardica To Present At 2014 Wedbush PacGrow Life Sciences Management Access

PR Newswire

REDWOOD CITY, Calif., Aug. 4, 2014

REDWOOD CITY, Calif., Aug. 4, 2014 /PRNewswire/ -- Cardica, Inc. (Nasdaq:
CRDC) today announced that Bernard A. Hausen, M.D., Ph.D., the company's
president and CEO, is scheduled to present a corporate overview and update at
the 2014 Wedbush PacGrow Life Sciences Management Access Conference on
Tuesday, August 12 at 12:45 p.m. Eastern Time.

To access the live and subsequently archived webcast of the presentation, go
to the Investor Relations section of the company's website at Please connect to the website at least 15 minutes
prior to the presentation to allow for any necessary software downloads.

About Cardica
Cardicadesigns and manufactures proprietary stapling and anastomotic devices
for laparoscopic and cardiac surgical procedures.Cardica's technology
portfolio is intended to reduce operating time and facilitate
minimally-invasive and robot-assisted surgeries. Cardica's MicroCutter
XCHANGE^® 30, a cartridge-based articulating surgical stapling device with a
five-millimeter shaft diameter, is manufactured and cleared for use in a
variety of gastrointestinal procedures and appendectomies in the United
States, and is marketed for a wide range of surgical procedures in Europe.
Cardicais developing the Cardica^® MicroCutter XCHANGE^® 45, a
cartridge-based microcutter device that is being designed with an
eight-millimeter shaft to be used in a variety of procedures, including
bariatric, colorectal, thoracic and general surgery. The Cardica MicroCutter
XCHANGE 45 product requires 510(k) clearance and CE Mark before it may be sold
in the United States and Europe, respectively, and is not yet commercially
available in the U.S. or internationally. In addition, Cardica manufactures
and markets its automated anastomosis systems, the C-Port^® Distal Anastomosis
Systems and PAS-Port^® Proximal Anastomosis System for coronary artery bypass
graft (CABG) surgery, and has shipped over 50,000 units throughout the world.

SOURCE Cardica

Contact: Bob Newell, Vice President, Finance and Chief Financial Officer,
(650) 331-7133,
Press spacebar to pause and continue. Press esc to stop.